EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles

Mohamed H Hekal iD, Abdullah Yahya Abdullah Alzahrani, Saad Alrashdi iD, Fatma S M Abu El-Azm iD, Yasmeen M Ali

RSC Advances · 2026 · 16 (25) · 22450-22464

DOI: 10.1039/d6ra02423h ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Mohamed H Hekal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Ain Shams University Abbassia 11566 Cairo Egypt mohamed.hekal@sci.asu.edu.eg. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New benzochromenopyrimidines were synthesized as potential EGFR inhibitors. Their antiproliferative activities were evaluated against cancer cell lines and normal fibroblasts. Compound 7 exhibited strong cytotoxicity and good selectivity.

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Ain Shams University Abbassia 11566 Cairo Egypt mohamed.hekal@sci.asu.edu.eg.
  • Department of Chemistry, Faculty of Science, King Khalid University Abha Saudi Arabia.
  • Department of Chemistry, College of Science, Jouf University Sakaka 72341 Aljouf Saudi Arabia.

ORCID-Profile: Mohamed H Hekal, Saad Alrashdi, Fatma S M Abu El-Azm

Zitieren

APA

Hekal, M. H., Abdullah Alzahrani, A. Y., Alrashdi, S., Abu El-Azm, F. S. M., & Ali, Y. M. (2026). New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles. RSC Advances, 16(25), 22450-22464. https://doi.org/10.1039/d6ra02423h

Vancouver

Hekal MH, Abdullah Alzahrani AY, Alrashdi S, Abu El-Azm FSM, Ali YM. New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles. RSC Advances. 2026;16(25):22450-22464. doi:10.1039/d6ra02423h

BibTeX
@article{Hekal2026,
  author = {Hekal, Mohamed H and Abdullah Alzahrani, Abdullah Yahya and Alrashdi, Saad and Abu El-Azm, Fatma S M and Ali, Yasmeen M},
  title = {New benzochromene-based compounds as potential EGFR-TK inhibitors: synthesis, anti-proliferative activity, molecular docking studies, and ADME profiles},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {25},
  pages = {22450--22464},
  doi = {10.1039/d6ra02423h}
}
Kostenlos starten →